Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AMN | Common Stock | Options Exercise | $0 | +1.68K | +68.98% | $0.00 | 4.12K | Apr 19, 2024 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AMN | Restricted Stock Units | Award | $0 | +3.02K | $0.00 | 3.02K | Apr 19, 2024 | Common Stock | 3.02K | Direct | F3, F4, F5 | ||
transaction | AMN | Restricted Stock Units | Options Exercise | $0 | -1.68K | -100% | $0.00 | 0 | Apr 19, 2024 | Common Stock | 1.68K | Direct | F3, F5, F6 |
Id | Content |
---|---|
F1 | AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). |
F2 | Due to an administrative error, the Form 4 filed by the reporting person on April 23, 2024 understated the amount of securities beneficially owned following the reported transaction by 2,000 shares. This Form 4 is being amended and restated to reflect that, following the reported transaction, 4,118 securities were beneficially owned by reporting person, not 2,118 as previously reported. |
F3 | The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. |
F4 | The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. |
F5 | RSUs do not have an expiration date. |
F6 | The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024. Accordingly, the number of RSUs identified in this row vested on April 19, 2024. |